Reply to Roesler et al. Comment on “Karaulic et al. Exploring Novel Applications: Repositioning Clinically Approved Therapies for Medulloblastoma Treatment. Cancers 2025, 17, 3659”

Key Points

• The aim is to address comments on repositioning existing therapies for medulloblastoma treatment.
• Review and synthesis of comments on prior research.
• Analysis of potential clinical applications of existing therapies.
• Affirmation of the importance of novel applications for existing therapies.
• Illustration of the therapeutic potential for improved treatment strategies in medulloblastoma.